Wei-Lin Ke1, Wei-Hua Zhao1, Xin-Yu Wang1. 1. Department of obstetrics, Shenzhen Second People's Hospital No.3002, West Sungang Road, Shenzhen, Guangdong, China.
Abstract
OBJECTIVE: The study aimed to validate the efficacy of detection of fetal cell-free DNA in maternal plasma of trisomy 21, 18 and 13 in a clinical setting. METHODS: A total of 2340 women at high risk for Down syndrome based on maternal age, prenatal history or a positive sesum or sonographic screening test were offered prenatal noninvasive aneuploidy test. According to the prenatal noninvasive aneuploidy test, the pregnant women at high risk were offered amniocentesis karyotype analysis and the pregnant at low risk were followed up to make sure the newborn outcome. RESULTS: The prenatal noninvasive aneuploidy test was positive for trisomy 21 in 17 cases, for trisomy 18 in 6 cases and for trisomy 13 in 1 case, which of all were confirmed by karyotype analysis. Newborns of low risk gestational woman detected by prenatal noninvasive aneuploidy for trisomy 21, 18, 13 were followed up and no one was found with trisomy. CONCLUSIONS: The prenatal noninvasive aneuploidy test is highly accurate for detection of trisomy 21, 18 and 13, which can be considered as a practical alternative for traditional invasive diagnostic procedures.
OBJECTIVE: The study aimed to validate the efficacy of detection of fetal cell-free DNA in maternal plasma of trisomy 21, 18 and 13 in a clinical setting. METHODS: A total of 2340 women at high risk for Down syndrome based on maternal age, prenatal history or a positive sesum or sonographic screening test were offered prenatal noninvasive aneuploidy test. According to the prenatal noninvasive aneuploidy test, the pregnant women at high risk were offered amniocentesis karyotype analysis and the pregnant at low risk were followed up to make sure the newborn outcome. RESULTS: The prenatal noninvasive aneuploidy test was positive for trisomy 21 in 17 cases, for trisomy 18 in 6 cases and for trisomy 13 in 1 case, which of all were confirmed by karyotype analysis. Newborns of low risk gestational woman detected by prenatal noninvasive aneuploidy for trisomy 21, 18, 13 were followed up and no one was found with trisomy. CONCLUSIONS: The prenatal noninvasive aneuploidy test is highly accurate for detection of trisomy 21, 18 and 13, which can be considered as a practical alternative for traditional invasive diagnostic procedures.
Entities:
Keywords:
Down syndrome; fetal cell-free DNA; prenatal noninvasive diagnosis
Authors: Thomas Lee; Erik S LeShane; Geralyn M Messerlian; Jacob A Canick; Antonio Farina; Walter W Heber; Diana W Bianchi Journal: Am J Obstet Gynecol Date: 2002-11 Impact factor: 8.661
Authors: Y M Dennis Lo; Nancy B Y Tsui; Rossa W K Chiu; Tze K Lau; Tse N Leung; Macy M S Heung; Ageliki Gerovassili; Yongjie Jin; Kypros H Nicolaides; Charles R Cantor; Chunming Ding Journal: Nat Med Date: 2007-01-07 Impact factor: 53.440
Authors: Diana W Bianchi; Lawrence D Platt; James D Goldberg; Alfred Z Abuhamad; Amy J Sehnert; Richard P Rava Journal: Obstet Gynecol Date: 2012-05 Impact factor: 7.661
Authors: Andrew B Sparks; Eric T Wang; Craig A Struble; Wade Barrett; Renee Stokowski; Celeste McBride; Jacob Zahn; Kevin Lee; Naiping Shen; Jigna Doshi; Michel Sun; Jill Garrison; Jay Sandler; Desiree Hollemon; Patrick Pattee; Aoy Tomita-Mitchell; Michael Mitchell; John Stuelpnagel; Ken Song; Arnold Oliphant Journal: Prenat Diagn Date: 2012-01-06 Impact factor: 3.050
Authors: Elisabeth M A Boormans; Erwin Birnie; Hajo I Wildschut; Heleen G Schuring-Blom; Dick Oepkes; Carla A C van Oppen; Jan G Nijhuis; Merryn V E Macville; Angelique J A Kooper; Karin Huijsdens; Mariëtte V J Hoffer; Attie Go; Johan Creemers; Shama L Bhola; Katia M Bilardo; Ron Suijkerbuijk; Katelijne Bouman; Robert-Jan H Galjaard; Gouke J Bonsel; Jan Mm van Lith Journal: BMC Pregnancy Childbirth Date: 2008-05-20 Impact factor: 3.007